US Venture Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches.
BiotechDigital HealthHealthtechMedical DevicesAspen, US
DEAN A. TRAVERS(Executive Officer, Director)SCOTT XIAO(Executive Officer, Director)Scott Xiao(Co-Founder & CEO)Dean Travers(Co-Founder)Brion Raymond(CBO)Drew Mowery(VP of Commercial Strategy)
Board seatCasey Tansey· per SEC Form D
Co-investorsShangBay Capital LLCBantam GroupGood FriendsNXT VenturesSony Ventures Corporation
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.